Pediatric Endocrinologist (Child Hormone Specialist)
My research focuses on investigation of the etiology and possible treatment for obesity and metabolic abnormalities in individuals with Prader-Willi syndrome and early-onset obesity. I have been working towards achieving an appropriate treatment for hyperphagia for the past 12 years. I currently follow over 500 patients with Prader-Willi syndrome from around the world, and over 100 patients with early-onset obesity due to other genetic causes. I am working on clinical treatment trials to treat hyperphagia in individuals with Prader-Willi syndrome and early-onset obesity..
To better understand the potential benefits of psychedelics in overeating disorders, Tryp Therapeutics will conduct a safety and feasibility clinical trial using TRP 8802 among individuals with Binge Eating Disorder. This is a single-center phase 2a鈥�
The primary objective of this study is to evaluate the safety and efficacy of pitolisant compared with placebo in treating excessive daytime sleepiness (EDS) in patients with Prader Willi syndrome (PWS) ages 6 to 65 years.
68 publications
2024
Journal of neurodevelopmental disorders
鈥�2024
Obesity (Silver Spring, Md.)
鈥�2024
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
鈥�2023
The Journal of Clinical Endocrinology & Metabolism
鈥�2023
Obesity science & practice
鈥�